Open AccessState Medicaid Hepatitis C Treatment Eligibility Criteria and Use of Direct-Acting Antivirals
Author(s) -
Shashi N. Kapadia,
Philip J. Jeng,
Bruce R. Schackman,
Yuhua Bao
Publication year - 2017
Publication title -
clinical infectious diseases
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 3.44
H-Index - 336
eISSN - 1537-6591
pISSN - 1058-4838
DOI - 10.1093/cid/cix1062
Subject(s) - medicaid , medicine , hepatitis c , family medicine , virology , health care , economics , economic growth
Medicaid program criteria for accessing hepatitis C treatment are changing. Medicaid drug utilization data from 2014 to 2016 show that programs that have relaxed their criteria have seen significant increases in treatment utilization, as have states with Medicaid expansions.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom